Literature DB >> 18085485

Long-term preservation of vision in progressive outer retinal necrosis treated with combination antiviral drugs and highly active antiretroviral therapy.

Stephen J Kim1, Robert Equi, Marie-Lyne Belair, Howard F Fine, James P Dunn.   

Abstract

PURPOSE: To report the successful long-term treatment of varicella zoster virus-associated progressive outer retinal necrosis (VZV-PORN) with aggressive antiviral combination drugs along with highly active antiretroviral therapy (HAART).
DESIGN: Interventional case report.
METHODS: Combined treatment of progressive outer retinal necrosis in a university-based tertiary eye hospital with ganciclovir implant, intravenous acyclovir (10 mg/kg every 8 h), intravitreal foscarnet (2.4 mg), and HAART.
RESULTS: Successful treatment of progressive outer retinal necrosis with disease remission and preservation of 20/20 visual acuity out to 1 year.
CONCLUSIONS: Combination antiviral therapy and HAART may improve long-term visual outcomes for VZV-PORN.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18085485     DOI: 10.1080/09273940701732255

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  4 in total

1.  A therapeutic challenge in AIDS-associated viral retinitis.

Authors:  S Yeh; L Lombardi; G Fahle; A K Lauer
Journal:  Eye (Lond)       Date:  2011-06-17       Impact factor: 3.775

Review 2.  Antimicrobial guide to posterior segment infections.

Authors:  Tapan P Patel; David N Zacks; Vaidehi S Dedania
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-11-06       Impact factor: 3.117

3.  Antiviral selection in the management of acute retinal necrosis.

Authors:  Patrick M K Tam; Claire Y Hooper; Susan Lightman
Journal:  Clin Ophthalmol       Date:  2010-02-02

Review 4.  Recent Updates on Treatment of Ocular Microbial Infections by Stem Cell Therapy: A Review.

Authors:  Seoh Wei Teh; Pooi Ling Mok; Munirah Abd Rashid; Mae-Lynn Catherine Bastion; Normala Ibrahim; Akon Higuchi; Kadarkarai Murugan; Rajan Mariappan; Suresh Kumar Subbiah
Journal:  Int J Mol Sci       Date:  2018-02-13       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.